With baseball at both the major and minor league levels now in full swing, the number of players in violation of the leagues’ drug policies are nearly twice that from the same time last year.
As of April 27, there have been 13 players (3 at the major league, and 10 at the minor league level) suspensions as part of their respective drug and treatment programs, compared to 7 players at this time in 2008 (1 at the major league level, and 5 at the minor league level), an increase of 86 percent.
Two players at the major league level, Sergio Mitre of the Yankees and J.C. Romero of the Phillies, were announced in January before the season began. Both players started their suspensions at the beginning of the season, with Mitre being with Triple-A Scranton/Wilkes-Barre. In the case of Romero, it was ruled via arbitration that he was negligent for using a nutritional supplement, purchased over the counter (6-OXO-Extreme), which was found to be tainted with androstendione.
Players found to be in violation of the Major League Drug Prevention and Treatment Program are simply reported as using “performance-enhancing drugs”. However, players at the minor league level are being announced with extra details.
Of the 10 that have been suspended, the substances break down as follows:
- Stanozolol – 4 ea.
- Nandrolone – 3 ea.
- Amphetamine – 1 ea.
- Drug of Abuse – 2 ea.
For a complete historical accounting of drug suspensions in both MLB and MiLB, see The Biz of Baseball’s “Drug Violations” page
Maury Brown is the Founder and President of the Business of Sports Network, which includes The Biz of Baseball, The Biz of Football, The Biz of Basketball and The Biz of Hockey. He is contributor to Baseball Prospectus, and is available as a freelance writer. Brown's full bio is here. He looks forward to your comments via email and can be contacted through the Business of Sports Network.
Don't forget to register and log in on The Biz of Baseball site to get updates via your in-box, and see information only logged in members can see.
Subscribe to The Biz of Baseball, and follow the Business of Sports Network on Twitter